Prostate Cancer

Prostate cancer is a type of cancer that develops in the prostate gland, which is a small walnut-shaped gland located below the bladder in men. The prostate gland produces seminal fluid that nourishes and transports sperm. Prostate cancer is one of the most common cancers in men, but with early detection and appropriate treatment, many cases can be effectively managed.

Causes and Risk Factors

The exact cause of prostate cancer is not fully understood, but certain risk factors can increase the likelihood of its development:

  • Age: Prostate cancer is more common in older men, with the risk increasing significantly after the age of 50.
  • Family History: Having a family history of prostate cancer, especially in a first-degree relative, can increase the risk.
  • Race/Ethnicity: African American men have a higher risk of developing prostate cancer, and it often tends to be more aggressive in this population.
  • Obesity: Being overweight or obese may increase the risk of developing aggressive forms of prostate cancer.


In the early stages, prostate cancer may not cause noticeable symptoms. As the cancer progresses, symptoms might include:

  • Frequent urination, especially at night.
  • Difficulty starting or stopping urination.
  • Weak or interrupted urine flow.
  • Blood in the urine or semen.
  • Erectile dysfunction.
  • Discomfort or pain in the pelvic area.


  • Prostate cancer is often detected through routine screenings, primarily the prostate-specific antigen (PSA) blood test and digital rectal examination (DRE).
  • If the PSA level is elevated or if an abnormality is felt during the DRE, further tests, such as a prostate biopsy, may be recommended.

Staging and Grading

  • Staging determines the extent and spread of the cancer within the prostate and nearby tissues. The TNM system (Tumor, Node, Metastasis) is commonly used for staging.
  • Grading is done using the Gleason score, which assesses the appearance of cancer cells under a microscope. The score helps predict how aggressive the cancer is.


  • Treatment options for prostate cancer depend on factors such as the stage of the cancer, the patient’s overall health, and individual preferences.
  • Active Surveillance: For low-risk cases, especially in older men, active surveillance involves closely monitoring the cancer without immediate treatment.
  • Surgery: Surgical removal of the prostate (prostatectomy) is a common treatment option, which can be done through open surgery or minimally invasive techniques like robotic-assisted surgery.
  • Radiation Therapy: High-energy radiation is used to target and kill cancer cells.
  • Hormone Therapy: Reducing levels of male hormones (androgens) can slow the growth of prostate cancer cells.
  • Chemotherapy: Medications are used to kill cancer cells or slow their growth.
  • Immunotherapy and Targeted Therapy: These newer approaches harness the immune system or target specific molecules involved in cancer growth.


The prognosis for prostate cancer varies widely based on factors like the stage at diagnosis, the aggressiveness of the cancer, and the effectiveness of treatment. Many cases of prostate cancer are slow-growing and may not require immediate aggressive treatment.

Screening, early detection, and open communication with healthcare providers are key factors in managing prostate cancer effectively. Regular check-ups and discussions with a healthcare provider can help determine the best course of action based on individual circumstances and preferences.

Accredited By